Acute respiratory pandemics: how to plan for and manage
This practical course will cover outbreak investigation, pandemic planning, recent developments in respiratory pathogen biology and therapy, and will focus around two practical scenarios in which participants will gain experience in managing an acute epidemic. Research during an epidemic and ethical aspects will also be covered.
ERS Training Course: Acute respiratory pandemics: how to plan and manage
This practical course covered outbreak investigation, pandemic planning, recent developments in respiratory pathogen biology and therapy, and focused around two practical scenarios in which participants could gain experience in managing an acute epidemic.
WHO recommendations for influenza virus vaccine composition for the 2018 southern hemisphere influenza season
The World Health Organization (WHO) has recommended the composition of the trivalent influenza vaccine for the southern hemisphere winter 2018 influenza season in a report published 28 September 2017.
Low uptake of seasonal influenza vaccination in Europe may jeopardise capacity to protect people in next pandemic
Influenza vaccination coverage among high-risk groups has dropped in the European Region over the last seven years, and half the countries report a decrease in the number of vaccine doses available.
Joint WHO/Europe–ECDC Annual European Influenza Surveillance Meeting, 2018
The joint annual influenza surveillance meeting by ECDC and the WHO Regional Office for Europe took place on 6 - 8 June 2018 in Copenhagen, Denmark. Invited participants were epidemiological and virological surveillance experts nominated by national health authorities as well as representatives from international institutions, covering the 53 countries of the EU/EEA and the WHO European region. The meeting was by invitation only.
The use of vaccines for prevention of seasonal and pandemic influenzaArchived
On 3 October 2011 European Centre for Disease Prevention and Control (ECDC) and representatives of the European Vaccine Manufacturers met at ECDC in Stockholm for a regular scheduled meeting about the use of vaccines for prevention of seasonal and pandemic influenza. ECDC Director Marc Sprenger opened the meeting and ECDC influenza experts held different presentations, such as burden of influenza disease in the EU, risk groups for severe influenza disease, personal protective measures, pandemic influenza preparedness, seasonal influenza vaccines, communication.
The Declarations of Interest for ECDC Influenza Staff and the ECDC Director are available here under ECDC Transparency.
4th Joint WHO/Europe–ECDC Annual European Influenza Surveillance Meeting 2014
WHO/Europe has been holding annual influenza surveillance meetings jointly with the European Centre for Disease Prevention and Control (ECDC) since 2011. This meeting brought together epidemiologists and virologists – the national influenza surveillance focal points – from 50 Member States to discuss national, regional and global surveillance related to seasonal influenza and novel influenza viruses, such as avian influenza A(H7N9).
Understanding the association between narcolepsy and one of the 2009 adjuvanted influenza A (H1N1) vaccines
This meeting was designed to offer a place to exchange the latest information on into the development of narcolepsy following vaccination with one of the 2009 adjuvanted influenza A(H1N1) vaccines.
The role of social networks in pandemic influenza transmission in and from schools – an example from the United StatesArchived
While there have been some early descriptive reports of school outbreaks, for example a number published in Eurosurveillance from France and the UK this study is unusual in combining modelling, social network theory and ‘shoe-leather epidemiology’.
Evidence from autopsies on the pathogenesis and pathological findings of the 2009 pandemic influenza A(H1N1) – implications for clinical care and disease burdenArchived
The first study, conducted in Europe during the 2009 pandemic addressed several objectives concerning the pathogenesis of the disease caused by the influenza A(H1N1) 2009 viruses.